0222 Novellus Fore EMB Mon 8a ET
BioCentury & Getty Images

Management Tracks

Fresh from $21B Gilead deal, Immunomedics vet Malik to lead newly rebranded precision medicines company Fore

Feb 22, 2021 | 1:01 PM GMT

Israeli diagnostics company Novellus has tapped former Immunomedics executive Usama Malik as its new CEO as it moves to the

Read the full 537 word article

How to gain access

Continue reading with a
two-week free trial.